Fierce Pharma
JUNE 6, 2023
Eisai is the latest drugmaker to be hit with a ransomware attack. | Eisai was the victim of a ransomware attack late Saturday night and is now working on response efforts, including the creation of a company-wide task force.
Medgadget
JUNE 6, 2023
Researchers at the University of California San Diego have created a wearable ultrasound system that can monitor deep tissues, as far as 16.5 cm (6.5 inches) below the surface of the body. Moreover, the team employed a machine learning algorithm to reduce the noise associated with movement, helping to obtain reliable readings while the wearer goes about their day.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Pharma
JUNE 6, 2023
Novo Holdings and Gurnet Point have added antibiotics maker Paratek Pharma to their fold in a biopharma M&A deal worth approximately $462 million. | Paratek's key selling point is its antibiotic, Nuzyra, which was expected to garner $500 million in peak sales at the time of its 2018 approval.
Pharmaceutical Technology
JUNE 6, 2023
Alkeus Pharmaceuticals has raised $150m in Series B financing to support the registration and launch of gildeuretinol (ALK-001) to treat Stargardt disease, a genetic cause of blindness in children and young adults. Led by Bain Capital Life Sciences, the financing round has also seen participation from Sofinnova Investments, TCGX and Wellington Management.
Fierce Pharma
JUNE 6, 2023
As GSK and Pfizer look to roll out their adult respiratory syncytial virus (RSV) vaccines later this year, Sanofi and AstraZeneca hope to join them on the market with an antibody designed to protec | As GSK and Pfizer look to roll out their adult RSV vaccines later this year, Sanofi and AstraZeneca hope to join them on the market with an antibody designed to protect infants.
Copyright Clearance Center
JUNE 6, 2023
The post The Supreme Court Case of Andy Warhol Foundation v. Goldsmith: What, if Anything, Does it Mean to Artificial Intelligence? appeared first on Copyright Clearance Center.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
Copyright Clearance Center
JUNE 6, 2023
On Wednesday, 14 June, CCC's Kevin Barrett will welcome Jamie Hullinger, solo corporate librarian of global medical technology leader Zimmer Biomet, for an informative 30-minute Q & A on navigating change and delivering value like a (solo information) pro.
PM360
JUNE 6, 2023
Inizio , a global commercialization partner dedicated to the health and life sciences industry, announced that Inizio Engage will now combine the strength, expertise, and proven track records of Ashfield Engage and The Creative Engagement Group (TCEG) into a unified global strategic, commercial, and creative engagement partner. Inizio Engage was initially announced as one of Inizio’s five business units when the organization formed in June 2022 from the combination of Huntsworth and Ashfield, bu
European Pharmaceutical Review
JUNE 6, 2023
A new global Minimized Risk of Antimicrobial Resistance (AMR) certification has been launched to promote and demonstrate responsible antibiotic manufacturing in the global pharmaceutical supply chain. BSI, a UK standards body, developed the new certification to the Antibiotic Manufacturing Standard published in June 2022. Standard for antibiotic manufacturing to help combat AMR … Following this “ground-breaking standard” stated Courtney Soulsby, BSI Global Director for Healthcare Sustainab
Pharmaceutical Technology
JUNE 6, 2023
Oragenics has secured funding from the Canadian bioresearch consortium CQDM to develop a variant-agnostic protein antigen for use in its Covid-19 intranasal vaccine. SynergiQC, the Quebec-based funding programme created by CQDM, has awarded the funding. The project is a partnership with Inspirevax and the National Research Council of Canada (NRC). In March 2023, Oragenics and Inspirevax entered an exclusive global licence deal to develop the former’s lead intranasal Covid-19 vaccine candidate, N
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
European Pharmaceutical Review
JUNE 6, 2023
Eighty-eight percent of lung cancer patients were alive after five years after being treated with AstraZeneca’s small molecule treatment TAGRISSO ® (osimertinib) in a Phase III trial. This was compared to 78 percent of patients on placebo in the overall trial population. The adjuvant treatment was given to early-stage (IB, II and IIIA) epidermal growth factor receptor-mutated (EGFRm) non-small cell lung cancer ( NSCLC ) patients following a complete tumour resection with curative intent.
MedCity News
JUNE 6, 2023
Many experts think technology will help mitigate healthcare’s burnout crisis and workforce shortage, but the healthcare industry still has a lot to figure out when it comes to choosing which tools to deploy and getting its workers on board with these new tools, according to a new report from GE HealthCare.
MedReps
JUNE 6, 2023
In order to find the best candidates for medical sales jobs, many companies turn to recruiters. They hire these recruiters to keep an eye on social media sites, LinkedIn and job boards in order to find workers who might be able to step into the jobs that need to be fulfilled. However, not all recruiters are created equally and some make mistakes that can lead to candidates being turned off by the company or even turned down for the job despite being qualified for it.
MedCity News
JUNE 6, 2023
FarmboxRx’s new program, called Feed by FarmboxRx, will supply 200 people affected by SNAP cuts with one box of mixed fresh produce and one box of pantry items each month for six months. They’ll also receive educational materials on how to prepare the food.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Medgadget
JUNE 6, 2023
Engineers at Ecole Polytechnique Fédérale de Lausanne (EPFL) in Switzerland have developed a new technology that can provide temperature feedback for amputees using a prosthetic limb. Excitingly, the device makes it feel as if the temperature sensation is experienced in the phantom limb, providing a realistic experience of touching something cold or hot with the missing limb.
MedCity News
JUNE 6, 2023
Pilotitis, a term commonly used in digital health to describe the tendency to launch numerous small-scale pilot projects without committing to or scaling pilots to full scale implementations. But while painful for many, it can also be a valuable tool for organizations and validate new ideas, build organizational resilience, build a culture of quantifying success, learn how to activate data, and actually improve clinical, organizational and innovation-related outcomes.
PharmaTimes
JUNE 6, 2023
The structure of NanoBone triggers bone-forming systems while also aiding rapid bone healing - News - PharmaTimes
MedCity News
JUNE 6, 2023
In response to the growing mental health need, Blue Cross Blue Shield of Massachusetts has grown its mental health provider network by 50% over the last five years to more than 18,000 clinicians.
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
PharmaTimes
JUNE 6, 2023
Rocketvax and Basel University therapy uses a modified coronavirus that activates an immune response - News - PharmaTimes
MedCity News
JUNE 6, 2023
Many physicians, podiatrists, psychologists, and occupational and physical therapists are able to take advantage of the ability to be an independent contractor with little scrutiny. Those who oppose it when it comes to nursing fail to see nurses as anything but a tax classification; they don’t understand that trying to corral nurses back into a system of work that does not work for them will only intensify the nursing shortage by exacerbating the flight from the workforce.
Medgadget
JUNE 6, 2023
Scientists at Purdue University have developed a urine test for early-stage Parkinson’s disease. The technology involves isolating extracellular vesicles of neural origin from urine samples and then assessing the proteins within the vesicles to detect biomarkers of the disease. The researchers have called their technology “EVtrap” (Extracellular Vesicles total recovery and purification) and it involves using magnetic beads to concentrate extracellular vesicles in urine, before subsequent proteom
PharmaTech
JUNE 6, 2023
Webinar Date/Time: Tuesday, June 27th, 2023 at 8am EDT | 1pm BST | 2pm CEST | 5am PDT Wednesday, June 28th, 2023 at 8am EDT | 1pm BST | 2pm CEST | 5am PDT Thursday, June 29th, 2023 at 8am EDT | 1pm BST | 2pm CEST | 5am PDT
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
Evolve Your Success
JUNE 6, 2023
Diversity is not just a goal; it’s a catalyst for innovation, progress, and the transformation of the medical sales industry. Welcome to another exciting episode of the Medical Sales podcast! To celebrate Pride Month, Samuel Adeyinka interviewed a remarkable guest named Trevor Boylston. Trevor stands out as a pivotal figure in the medical sales industry by using his voice to advocate for the LGBTQ+ community.
Spotio
JUNE 6, 2023
Are you in the direct sales game? Would you like to close more deals, drive more revenue, and earn bigger commission checks? You’ve come to the right place. In this article, we share 11 practical direct sales tips. Once you implement them, you’ll achieve more success and become the sales superstar you’ve always wanted to be. Sound interesting?
Clarify Health
JUNE 6, 2023
Innovation will accelerate insights into influenceable behaviors that reduce costs and improve outcomes. San Francisco, CA (June 6, 2023) – Clarify Health , an an innovative leader in healthcare analytics and value-based payment solutions, is thrilled to announce the closed beta launch of its revolutionary generative artificial intelligence (AI), Clara.
Copyright Clearance Center
JUNE 6, 2023
Andrew Robinson summarizes a recent CCC webcast in a blog post. He writes the following: In early May, CCC hosted 'Workflow of the Future: Sustainable Business Models,' the fifth event in a series designed to help facilitate important conversations on critical topics related to standards, including sustainability.
Advertisement
Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic
PM360
JUNE 6, 2023
Cardinal Health announced it has signed a definitive agreement to contribute its Outcomes business to Transaction Data Systems (TDS), a portfolio company of BlackRock Long Term Private Capital and GTCR, in exchange for a minority stake in the combined entity. Under the terms of the agreement, Cardinal Health’s pharmaceutical segment CEO, Debbie Weitzman , will be appointed to the TDS board of directors.
Pharmaceutical Technology
JUNE 6, 2023
The global pharma industry experienced an 11% rise in social media posts on big data in Q1 2023 compared with the previous quarter, with the highest share accounted for Eli Lilly and Co, according to GlobalData’s analysis of social media posts. The big data landscape is rapidly evolving and pharma companies are increasingly integrating big data analytics into their value chains.
Legacy MEDSearch
JUNE 6, 2023
Artelon Inc., announced today U.S. FDA 510(k) clearance of FlexBand®, FlexPatch®, and FlexBand Plus® for ligament repair surgery in addition to tendon repairs*. This new clearance expands the indications for these products to now include reinforcement of medial, lateral and ulnar collateral ligaments, spring ligaments, deltoid ligaments, and extra-articular ligaments in the ankle, knee, and other joints around the body.
Clarify Health
JUNE 6, 2023
Innovation will accelerate insights into influenceable behaviors that reduce costs and improve outcomes. San Francisco, CA (June 6, 2023) – Clarify Health , an innovative leader in healthcare analytics and digital solutions, is thrilled to announce the closed beta launch of its revolutionary generative artificial intelligence (AI) co-pilot, Clara. This groundbreaking technology is set to empower healthcare delivery organizations to access insights into influenceable behavior changes that matter
Advertisement
As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.
Expert insights. Personalized for you.
233 
Let's personalize your content